<description>&lt;p&gt;In this episode of JCO Article Insights, host Dr. Lauren Shih summarizes the article, "&lt;a href= "https://ascopubs.org/doi/10.1200/JCO-25-00272" target="_blank" rel="noopener"&gt;Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study&lt;/a&gt;" by Bourhis, et al published September 03, 2025&lt;/p&gt; &lt;p&gt;&lt;span style= "text-decoration: underline;"&gt;&lt;strong&gt;TRANSCRIPT&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt; &lt;p&gt; &lt;/p&gt;</description>

Journal of Clinical Oncology (JCO) Podcast

American Society of Clinical Oncology (ASCO)

JCO Article Insights: Xevinapant Plus Chemoradiotherapy in Unresected LA SCCHN

OCT 27, 20258 MIN
Journal of Clinical Oncology (JCO) Podcast

JCO Article Insights: Xevinapant Plus Chemoradiotherapy in Unresected LA SCCHN

OCT 27, 20258 MIN

Description

In this episode of JCO Article Insights, host Dr. Lauren Shih summarizes the article, "Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study" by Bourhis, et al published September 03, 2025

TRANSCRIPT